NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Trilliome

Trilliome

Private
ZurichHealthcare & Life Scienceshttps://trilliome.com/

Last Round

Accelerator

Nov 18, 2025

Total Funding Raised

$378,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Trilliome is a biotechnology company developing plant-derived, clinically validated ingredients that precisely modulate keystone gut microbial networks and their metabolites to target hallmarks of aging.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Circular Economy

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

microbiome ingredientsgut-brain axisprecision prebioticsbioactive ingredientspsychobioticsgut healthcognitive health ingredientsnutraceutical ingredientsfunctional food ingredientsplant-derived ingredientslongevity ingredientsnootropic ingredientsGRASGenerally Recognized as Safeupcycled ingredientsbiotech consulting

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Trilliome Comparables

Compare Trilliome with similar companies based on industry and business-model similarity.

Trilliome comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Trilliome Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorNov 18, 2025
GrantOct 17, 2025
GrantFeb 19, 2025
GrantNov 19, 2024

Key People

Founding team and executive leadership

Patrick Guye

CEO, Co-founder, Managing Partner

Founding Team

Christoph Schäfer

Fractional CFO

Executive Team

Trilliome Investors

Notable investors and investment history

Trilliome investors
InvestorRounds
Biotope by VIBAccelerator
EIT FoodGrant
Venture KickGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 18, 2025

    $270K raised from Biotope by VIB

  • Oct 17, 2025

    $53K grant received from EIT Food.

Trilliome Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Trilliome Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Trilliome's valuation, stock price, and market status.

Firmographic Details

HeadquartersZurich
Employee Range4
Year Founded2023
Last FundingNov 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.